MARK1/2/3/4 Polyclonal Antibody

Alias:MARK1;KIAA1477;MARK;Serine/threonine-protein kinase MARK1;MAP/microtubule affinity-regulating kinase 1;PAR1 homolog c;Par-1c;Par1c;MARK2;EMK1;Serine/threonine-protein kinase MARK2;ELKL motif kinase 1;EMK-1;MAP/microtubule affin

CatalogNo:HJRLT2650

Specifications

50μL;100μL

Delivery date

Spot

Target

MARK1/2/3/4

Reactivity

Human,Mouse,Rat,Monkey

Application - After Update

WB,IHC,IF,ELISA

MW(Observed)

89kD

Host Species

Rabbit

Isotype

IgG

Modify

Unmodified

Recommended dilution ratio

WB 1:500-1:2000;IHC 1:100-1:300;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.

compose

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Store

-15°C to -25°C/1 year(Do not lower than -25°C)

Soncentration

1 mg/ml

Clonality

Polyclonal

Immunogen

The antiserum was produced against synthesized peptide derived from human MARK1/2/3/4. AA range:181-230

Specificity

MARK1/2/3/4 Polyclonal Antibody detects endogenous levels of MARK1/2/3/4 protein.

Gene name

MARK1/2/3/4

Protein name

Serine/threonine-protein kinase MARK1/2/3/4

Organism-1

Human